✦ LIBER ✦

236 Global Endpoints in IBS Clinical Trials: Results from a Phase 2B Study of Linaclotide

✍ Scribed by Jeffrey M. Johnston; James E. MacDougall; Bernard J. Lavins; Anthony J. Lembo; Harvey Schneier; Steven J. Shiff; Caroline B. Kurtz; Mark G. Currie

Book ID: 119430064
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 236 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(09)60207-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

157 Effect of Linaclotide On IBS-C Sympt

157 Effect of Linaclotide On IBS-C Symptoms in the First Week of Treatment: Results from a Phase 2B Study

✍ Anthony J. Lembo; Jeffrey M. Johnston; Bernard J. Lavins; James E. MacDougall; H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Randomised clinical trials: linaclotide

Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints

✍ Quigley, E. M. M.; Tack, J.; Chey, W. D.; Rao, S. S.; Fortea, J.; Falques, M.; D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

418 Effect of Linaclotide On Quality of

418 Effect of Linaclotide On Quality of Life in Adults with Chronic Constipation: Results from a Phase 2B Study

✍ Bernard J. Lavins; Jeffrey M. Johnston; James E. MacDougall; Anthony J. Lembo; H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 153 KB

T1817 Results From the Randomized Withdr

T1817 Results From the Randomized Withdrawal Period of a Phase 3 Clinical Trial of Linaclotide in Chronic Constipation

✍ Johnston, Jeffrey M.; Schneier, Harvey; Lavins, Bernard J.; Shiff, Steven J.; Ma 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB

T1273 Time to Onset of Linaclotide Effec

T1273 Time to Onset of Linaclotide Effect On the Bowel Habits in Patients with Chronic Constipation: Results from a Phase 2B Study

✍ Johnston, Jeffrey M.; Lavins, Bernard J.; MacDougall, James E.; Lembo, Anthony J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Efficacy and Safety of Once-Daily Linacl

Efficacy and Safety of Once-Daily Linaclotide Administered Orally for 26 Weeks in Patients With IBS-C: Results From a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

✍ William D. Chey; Anthony Lembo; James E. MacDougall; Bernard J. Lavins; Harvey S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB